{
    "clinical_study": {
        "@rank": "70691", 
        "brief_summary": {
            "textblock": "This study is to evaluate the safety and effectiveness of an injectable slow releasing\n      preparation of naltrexone to reduce alcohol consumption and risk of relapse in\n      alcohol-dependent subjects.  Individuals will receive either naltrexone or a placebo\n      injection for a total of three months, with two subsequent followup visits spanning a 6-\n      month period."
        }, 
        "brief_title": "Naltrexone for Relapse Prevention", 
        "completion_date": "December 2002", 
        "condition": "Alcoholism", 
        "condition_browse": {
            "mesh_term": "Alcoholism"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meets criteria for alcohol dependence.\n\n          -  Abstinent from alcohol for a period of at least 3 days prior to beginning of study.\n\n          -  Able to read English and complete study evaluations.\n\n          -  Females who are postmenopausal, have had surgical sterilization, or use reliable\n             means of birth control.\n\n        Exclusion Criteria:\n\n          -  Meets criteria for dependence on a psychoactive substance other than alcohol and\n             nicotine and/or cannabis.\n\n          -  Prior history of opioid dependence.\n\n          -  Regular use of psychoactive drugs including anxiolytics and antidepressants.\n\n          -  Prior treatment with naltrexone.\n\n          -  Current use of disulfiram.\n\n          -  Psychotic or otherwise severely psychiatrically disabled (e.g., suicidal, current\n             mania).\n\n          -  Significant underlying medical conditions such as hepatic, cerebral, renal, thyroid,\n             or cardiac disease.\n\n          -  Abstinent longer than 28 days prior to randomization."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "57", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000442", 
            "org_study_id": "NIAAAKRA3510", 
            "secondary_id": "P50AA003510"
        }, 
        "intervention": {
            "intervention_name": "naltrexone (Revia)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Naltrexone"
        }, 
        "lastchanged_date": "June 17, 2011", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19103"
                }, 
                "name": "Department of Psychiatry, University of Pennsylvania"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Etiology and Treatment of Alcohol Dependence", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 4", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000442"
        }, 
        "responsible_party": {
            "name_title": "Henry Kranzler", 
            "organization": "University of Pennsylvania"
        }, 
        "source": "University of Connecticut Health Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Connecticut Health Center", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2011"
    }, 
    "geocoordinates": {
        "Department of Psychiatry, University of Pennsylvania": "39.952 -75.164"
    }
}